Abstract

There is growing experimental evidence that many respiratory viruses—including influenza and SARS-CoV-2—can interact, such that their epidemiological dynamics may not be independent. To assess these interactions, standard statistical tests of independence suggest that the prevalence ratio—defined as the ratio of co-infection prevalence to the product of single-infection prevalences—should equal unity for non-interacting pathogens. As a result, earlier epidemiological studies aimed to estimate the prevalence ratio from co-detection prevalence data, under the assumption that deviations from unity implied interaction. To examine the validity of this assumption, we designed a simulation study that built on a broadly applicable epidemiological model of co-circulation of two emerging or seasonal respiratory viruses. By focusing on the pair influenza–SARS-CoV-2, we first demonstrate that the prevalence ratio systematically underestimates the strength of interaction, and can even misclassify antagonistic or synergistic interactions that persist after clearance of infection. In a global sensitivity analysis, we further identify properties of viral infection—such as a high reproduction number or a short infectious period—that blur the interaction inferred from the prevalence ratio. Altogether, our results suggest that ecological or epidemiological studies based on co-detection prevalence data provide a poor guide to assess interactions among respiratory viruses.

Highlights

  • The pandemic of coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emphasized the persistent threat posed by respiratory viruses

  • We aimed to determine whether the prevalence ratio—defined as the ratio of the prevalence of co-infection to the product of individual infection prevalences—enabled reliable estimation of interactions between respiratory viruses

  • By focusing on the pair influenza–SARS-CoV-2, we first demonstrated that the prevalence ratio systematically underestimated the strength of interaction, and could even mistake the sign of interactions that persisted after clearance of infection

Read more

Summary

Introduction

The pandemic of coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emphasized the persistent threat posed by respiratory viruses. Vaccines against a target pathogen may indirectly affect non-target pathogens that interact with this target pathogen—an effect expected (by the law of signs) to reduce the non-target pathogen burden in case of positive interactions, and to increase it in case of negative interactions [11,12,13] Because of their relevance to epidemiology and public health, a natural question is how best to identify and estimate interactions between respiratory viruses. Challenge studies in animals or humans provide the strongest form of evidence, because they can pinpoint the within-host mechanisms of interaction in a controlled experimental setting. We argue that earlier epidemiological studies based on this design should be interpreted with caution and that further longitudinal studies will be needed to elucidate the epidemiological interactions of SARS-CoV-2 with other respiratory viruses

Methods
À p1 À PR Â
Results
Discussion
Findings
32. Morris DH et al 2021 Mechanistic theory predicts
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call